|
Volumn 79, Issue 4, 2004, Pages 163-168
|
Efficiency of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers;Eficacia de brimonidina 0,2% y dorzolamida 2% como tratamiento adyuvante a un beta-bloqueante.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRIMONIDINE;
DORZOLAMIDE;
EYE DROPS;
QUINOXALINE DERIVATIVE;
SULFONAMIDE;
THIOPHENE DERIVATIVE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
MULTICENTER STUDY;
OCULOPLETHYSMOGRAPHY;
OPEN ANGLE GLAUCOMA;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
ANTIHYPERTENSIVE AGENTS;
DRUG THERAPY, COMBINATION;
GLAUCOMA, OPEN-ANGLE;
HUMANS;
INTRAOCULAR PRESSURE;
OCULAR HYPERTENSION;
OPHTHALMIC SOLUTIONS;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
QUINOXALINES;
SULFONAMIDES;
THIOPHENES;
TONOMETRY, OCULAR;
TREATMENT OUTCOME;
|
EID: 4344698997
PISSN: 03656691
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|